SciTransfer
Organization

ROAL OY

Finnish industrial biotech company specialising in PHA biopolymer production and microbial upcycling of mixed plastic waste.

Large industrial companyenvironmentFINo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
Unique partners
28
What they do

Their core work

ROAL OY is a Finnish industrial biotechnology company based in Rajamäki, active in the bio-based industries sector. Their H2020 projects span sustainable cellulose material production and microbial plastic upcycling, indicating deep expertise in industrial fermentation and bioprocess engineering. In research consortia, they function as an industrial partner capable of translating laboratory-scale biotechnology into commercially viable processes — contributing production know-how that academic partners typically lack. Their participation in BBI-JU-funded projects signals deliberate alignment with the EU's bio-based industries agenda, particularly around converting biological feedstocks and waste plastics into value-added biopolymers.

Core expertise

What they specialise in

Biobased polymer production (PHA / polyhydroxyalkanoate)primary
1 project

The MIX-UP project (2020–2024) focuses on biodegradation and upcycling of mixed plastics into PHA using microbial communities, where ROAL OY contributed specialist capacity as a third party.

Microbial engineering and synthetic biology for plastic valorisationprimary
1 project

MIX-UP keywords include metabolic engineering, microbial consortia, depolymerisation, and mixed plastics valorisation — applied domains where ROAL OY's industrial bioprocess expertise is directly relevant.

Sustainable cellulose-based materials processingsecondary
1 project

Participation in NeoCel (2016–2019), a project developing novel processes for sustainable cellulose-based materials, reflects established industrial fermentation or enzyme process capability.

Industrial scale-up of bio-based processes (BBI ecosystem)secondary
2 projects

Engagement across both BBI-RIA and standard RIA funding schemes — frameworks explicitly designed to bridge lab-scale biotechnology and industrial production — positions ROAL OY as a commercial anchor within research consortia.

Evolution & trajectory

How they've shifted over time

Early focus
Cellulose materials and bioeconomy inputs
Recent focus
PHA production from mixed plastic waste

ROAL OY's first H2020 engagement (NeoCel, 2016–2019) was in sustainable cellulose material innovation — a bioeconomy-adjacent domain with no publicly reported keywords, suggesting a materials supply or industrial process support role rather than a research-driving one. By 2020–2024 (MIX-UP), their focus shifted decisively toward plastic crisis solutions: PHA biopolymer production from mixed plastic waste, synthetic biology, and microbial consortia engineering. This trajectory mirrors the broader EU policy pivot from bio-based input materials toward circular economy outputs, and shows ROAL OY actively repositioning from biorefinery feedstock processing toward next-generation plastic alternatives.

ROAL OY is moving toward microbial plastic upcycling and biopolymer manufacturing — a fast-growing area where industrial-scale fermentation capacity is scarce and highly sought-after in EU research consortia.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European10 countries collaborated

ROAL OY has not held a coordinator role in any H2020 project, consistently joining as a participant or third party — a pattern typical of industrial companies that contribute specialized production or process-testing capacity rather than leading research agendas. Despite only two projects, they have accumulated 28 unique consortium partners across 10 countries, indicating participation in large, multi-stakeholder consortia where their industrial expertise complements academic and SME partners. This makes them a dependable but operationally focused collaborator rather than a strategic driver of project direction.

ROAL OY has built a surprisingly broad network for an organization with only two projects: 28 unique partners across 10 countries, reflecting participation in the large multi-partner consortia typical of BBI-JU and Horizon RIA calls rather than narrow bilateral collaborations.

Why partner with them

What sets them apart

As a non-SME industrial company in the bio-based industries space, ROAL OY brings commercial-scale fermentation and bioprocess expertise that is often the missing link in consortia dominated by academic institutions. Their presence in both cellulose material innovation and plastic waste upcycling gives them a cross-cutting profile across two of the EU bioeconomy's most active research themes. For consortium builders, ROAL OY represents an industrial anchor that can ground biotechnology research in real production constraints and accelerate the path from bench to market.

Notable projects

Highlights from their portfolio

  • NeoCel
    An early bioeconomy project (2016–2019) on novel cellulose-based material processes, marking ROAL OY's entry into EU research collaboration and their initial positioning within the Bio-Based Industries ecosystem.
  • MIX-UP
    A BBI-JU funded project (2020–2024) addressing the plastic crisis by engineering microbial communities to biodegrade and upcycle mixed plastics into PHA biopolymers — one of the most commercially actionable plastic valorisation approaches in the EU H2020 portfolio.
Cross-sector capabilities
Food & Agriculture — industrial enzyme and fermentation processes applicable to food ingredient, feed additive, and biorefinery productionManufacturing — PHA biopolymer production as a bio-based drop-in replacement for conventional plastics in industrial supply chainsChemicals & Bioeconomy — microbial valorisation of organic waste streams into high-value bio-based chemicals and polymers
Analysis note: Profile is based on only two projects; the first (NeoCel) carries no keyword data, limiting insight into early-period expertise. EC funding figures are unavailable, preventing budget-based weighting of contributions. The analysis is directionally sound but should be treated as indicative — data from company reports or project deliverables would substantially strengthen it.